Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/1/1999
1.
Phase II Randomized Study of Doxorubicin with vs without VX-710 (a Multidrug Resistance Inhibitor) for Inoperable Primary Hepatocellular Carcinoma (Summary Last Modified 05/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
VX-96-710-003
NCI-V96-0931
Last Modified:
5/1/1999
2.
Multicenter Phase II Study of VX-710 in Combination with Paclitaxel in Women with Metastatic or Locally Advanced Breast Cancer that is Refractory to Paclitaxel (Summary Last Modified 05/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
VX-96-710-004
NCI-V97-1200
Last Modified:
2/26/2007
 
First Published:
7/1/1999
3.
Phase II Study of VX-710, Doxorubicin, and Vincristine in Patients with Recurrent Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
VX-98-710-006
DUMC-1450-98-9, NCI-V99-1537, NCT00003847
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute